Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens

The human Vγ9Vδ2 T cell is a unique cell type that holds great potential in immunotherapy of cancer. In particular, the therapeutic potential of this cell type in adoptive cell therapy (ACT) has gained interest. In this regard optimization of in vitro expansion methods and functional characterizatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Holmen Olofsson, Gitte, Idorn, Manja, Carnaz Simões, Ana Micaela, Aehnlich, Pia, Skadborg, Signe Koggersbøl, Noessner, Elfriede, Debets, Reno, Moser, Bernhard, Met, Özcan, thor Straten, Per
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8208807/
https://ncbi.nlm.nih.gov/pubmed/34149689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.645131
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados